Aprazer Healthcare Launched XGRAF

October 1, 2021
Posted by Aprazer

11 Jan

Launch Date: 11/01/21

Aprazer Healthcare Launched XGRAF (Tacrolimus Capsules ) which is used for the prophylaxis of organ rejection in adults and paediatric patients receiving kidney transplant, liver transplant and heart transplant, in combination with other immunosuppressant’s.

Newer Aprazer Healthcare Launched SUTEKAST

Older Aprazer Healthcare Launched MEROAXIS

Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.